β-HB inhibits the apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis
OBJECTIVE: Nerve damage can cause severe limb dysfunction and even leave a lifelong disability. The apoptosis of astrocytes may contribute to the nerve damage. In this research, we sought to investigate the effect of β-HB on nerve damage in vitro.
DESIGN: Astrocytes were treated with high glucose (HG) to mimic in vitro model of nerve damage. RT-qPCR and western blot were used to detect expressions of CREB, BDNF, Ki-67, PCNA, Bax, Bcl-2 and cleaved caspase 3 in astrocytes, respectively. MTT was used to measure the cell viability. In addition, flow cytometry was used to detect the cell apoptosis.
RESULTS: β-HB significantly promoted the proliferation and inhibited apoptosis in HG-treated astrocytes. Results showed that of PCNA and Bcl-2 were upregulated, and Bax and cleaved caspase 3 were downregulated after β-HB stimulated in HG-treated astrocytes. In addition, HG-induced inhibition on BDNF expression in astrocytes was notably reversed by β-HB. Furthermore, β-HB promoted the growth and inhibited apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis.
CONCLUSION: β-HB promotes the growth and inhibits the apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis, which may serve as a new target for treatment of nerve damage.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Brain injury - 35(2021), 10 vom: 24. Aug., Seite 1201-1209 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Lei [VerfasserIn] |
---|
Links: |
---|
Themen: |
β-HB |
---|
Anmerkungen: |
Date Completed 11.10.2021 Date Revised 11.10.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/02699052.2021.1959061 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329274686 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329274686 | ||
003 | DE-627 | ||
005 | 20231225204748.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/02699052.2021.1959061 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329274686 | ||
035 | |a (NLM)34383626 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Lei |e verfasserin |4 aut | |
245 | 1 | 0 | |a β-HB inhibits the apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.10.2021 | ||
500 | |a Date Revised 11.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: Nerve damage can cause severe limb dysfunction and even leave a lifelong disability. The apoptosis of astrocytes may contribute to the nerve damage. In this research, we sought to investigate the effect of β-HB on nerve damage in vitro | ||
520 | |a DESIGN: Astrocytes were treated with high glucose (HG) to mimic in vitro model of nerve damage. RT-qPCR and western blot were used to detect expressions of CREB, BDNF, Ki-67, PCNA, Bax, Bcl-2 and cleaved caspase 3 in astrocytes, respectively. MTT was used to measure the cell viability. In addition, flow cytometry was used to detect the cell apoptosis | ||
520 | |a RESULTS: β-HB significantly promoted the proliferation and inhibited apoptosis in HG-treated astrocytes. Results showed that of PCNA and Bcl-2 were upregulated, and Bax and cleaved caspase 3 were downregulated after β-HB stimulated in HG-treated astrocytes. In addition, HG-induced inhibition on BDNF expression in astrocytes was notably reversed by β-HB. Furthermore, β-HB promoted the growth and inhibited apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis | ||
520 | |a CONCLUSION: β-HB promotes the growth and inhibits the apoptosis of high glucose-treated astrocytes via activation of CREB/BDNF axis, which may serve as a new target for treatment of nerve damage | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a CREB/BDNF axis | |
650 | 4 | |a astrocytes | |
650 | 4 | |a nerve damage | |
650 | 4 | |a β-HB | |
650 | 7 | |a Brain-Derived Neurotrophic Factor |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
700 | 1 | |a Dong, Da-Long |e verfasserin |4 aut | |
700 | 1 | |a Gao, Jun-Hong |e verfasserin |4 aut | |
700 | 1 | |a Wang, An-Kui |e verfasserin |4 aut | |
700 | 1 | |a Shao, Yong-Ping |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Brain injury |d 1996 |g 35(2021), 10 vom: 24. Aug., Seite 1201-1209 |w (DE-627)NLM012918857 |x 1362-301X |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2021 |g number:10 |g day:24 |g month:08 |g pages:1201-1209 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/02699052.2021.1959061 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2021 |e 10 |b 24 |c 08 |h 1201-1209 |